📊CDC Seeks Comments on Suicide Prevention Program Information Collection
The CDC submitted a request for information collection regarding the Performance Monitoring of its Comprehensive Suicide Prevention Program. This includes gathering data to enhance reporting on suicide trends and to ensure program effectiveness. Stakeholders and agencies are invited to comment on the proposed changes within a specified period.
Learn More💉CDC Advisory Meeting on Vaccines – Business Implications
In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC) announces an amendment to the following meeting of the Advisory Committee on Immunization Practices (ACIP). The meeting is open to the public.
Learn More🏥CDC Notice on Information Collection for Tuberculosis Program
The CDC has submitted a request for information collection under the Paperwork Reduction Act, specifically for the "Aggregate Reports for Tuberculosis Program Evaluation." This includes a 30-day comment period for the public and agencies to assess the necessity and utility of the proposed data collection efforts aimed at eliminating tuberculosis in the U.S.
Learn More🚬Proposed CDC Data Collection on Smokeless Tobacco Ingredients
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a continuing information collection project titled Annual Submission of the Ingredients Added to, and the Quantity of Nicotine Contained in, Smokeless Tobacco Manufactured, Imported, or Packaged in the U.S. This activity is designed to allow CDC to collect a list of ingredients added to tobacco in the manufacture of smokeless tobacco products and a specification of the quantity of nicotine contained in each product.
Learn More🏭CDC Proposes Data Collection on Cigarette Ingredients
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies the opportunity to comment on a continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a continuing information collection project titled List of Ingredients Added to Tobacco in the Manufacture of Cigarette Products. This data collection is developed so that cigarette manufacturers, packagers, and importers can submit annually to HHS (through CDC) a list of ingredients added to tobacco in the manufacturing of cigarettes.
Learn More🧪CDC Requests Comments on Drug Susceptibility Testing Program
The CDC has submitted an information collection request for the Model Performance Evaluation Program related to Mycobacterium tuberculosis drug susceptibility testing. This initiative aims to enhance the quality of testing practices among U.S. laboratories. The program is designed to provide evaluations that help optimize laboratory capabilities in identifying drug-resistant tuberculosis strains, thereby informing continuous program improvement.
Learn More📄CDC Notice on Sudden Death in the Young Information Collection
The CDC announces a proposed information collection titled "Sudden Death in the Young," inviting public and agency comments on the collection's necessity and methodology. This process follows previous outreach for public feedback and aims to enhance data accuracy regarding child death incidences. The notice includes a call for comments within 30 days, highlighting the agency's collaborative efforts to improve health data collection.
Learn More🏥CDC Seeks Input on CAUTI Surveillance for SCI-NB Patients
The Centers for Disease Control and Prevention (CDC), in the Department of Health and Human Services (HHS), is seeking information regarding Catheter-associated Urinary Tract Infections (CAUTIs) among patients with Spinal Cord Injury-associated Neurogenic Bladder (SCI- NB). We want to understand better the burden of CAUTIs among this patient population and any implications related to reporting within the CDC National Healthcare Safety Network (NHSN) device-associated urinary tract infection (UTI) event module. This docket provides an opportunity for professionals who work with this patient population, as well as those who conduct NHSN UTI surveillance, to offer feedback related to our approach.
Learn More🧪CDC Proposes Data Collection for Opioid Material Distribution
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Distribution of Traceable Opioid Material[supreg] Kits (TOM[supreg] Kits) across U.S. and International Laboratories. The purpose of this information collection request (ICR) is for the CDC to assure that the Traceable Opioid Material[supreg] Kits (TOM[supreg] Kits) are equitably distributed to domestic and international partner laboratories, and to allow CDC to understand the types of laboratories requesting these materials and the analyses that are being conducted.
Learn More📄CDC Notice on Training Application Paperwork Review and Changes
The CDC has submitted an information collection request for a training application to OMB for review under the Paperwork Reduction Act. This notice invites additional public comments and outlines modifications to the data collection processes for health training programs to improve efficiency and compliance with accreditation standards.
Learn More